Recombinant Human Transforming Growth Factor Beta 3 Accelerates Gastric Ulcer Healing in Rats

References

• Szabo S, Kusstatscher S, Sandor Z, Sakoulas G. Molecular and cellular basis of ulcer healing. Scand J Gastroenterol 1995; 30: 3–8, Suppl 208
   Web of Science ®Google Scholar
• Bianchi PG. De-Nol G: a new concept in cytoprotection. Scand J Gastroenterol 1986; 21: 1–54, Suppl 122
   PubMed Web of Science ®Google Scholar
• Robert A. Cytoprotection by prostaglandins. Gastroenterology 1979; 77: 761–7
   PubMed Web of Science ®Google Scholar
• Konturek SJ, Dembinski A, Warzecha Z, Brzozowski T, Gregory H. Role of epidermal growth factor in healing of chronic gastroduodenal ulcers in rats. Gastroenterology 1988; 94: 1300–7
   PubMed Web of Science ®Google Scholar
• Folkinann J, Szabo S, Stovroff M, McNeil P, William Li, Shing Y. Duodenal ulcer: discovery of a new mechanism and development of angiogenetic therapy that accelerates healing. Ann Surg 1991; 214: 414–26
   PubMed Web of Science ®Google Scholar
• Guglietta A, Hervada T, Nardi RV, Lesch CA. Effect of platelet derived growth factor-BB on indomethacin-induced gastric lesions in rats. Scand J Gastroenterol 1992; 27: 673–6
   PubMed Web of Science ®Google Scholar
• Roberts AB, Sporn MB. The transforming growth factor-βs. Handbook of experimental pharmacology: peptide growth factors and their receptors., MB Sporn, AB Roberts. Springer-Verlag, New York 1990; 419–72
   Google Scholar
• Massagué J, Hata A, Liu F. TGF signalling through the Smad pathway. Trends Cell Biol 1997; 7: 187–92
   PubMed Web of Science ®Google Scholar
• Schmid P, Cox D, Bilbe G, McMaster G, Morrison G, Slahelin H, et al. TGF-βs and TGF-β type II receptor in human epidermis: differential expression in acute and chronic skin wounds. J Pathol 1993; 171: 191–7
   PubMed Web of Science ®Google Scholar
• McMullen H, Longaker MT, Cabrera R, Sung J, Canete J, Siebert JW, et al. Spatial and temporal expression of transforming growth factor-β isoformsduring bovine excisional and incisional wound repair. Wound Rep Reg 1994; 3: 141–56
   Google Scholar
• Wang JX, Greenhalgh DA, Bickenbach JR, Liang A, Bundman DS, Krieg T, et al. Expression of a dominant-negative type II transforming growth factor β (TGF-β) receptor in the epidermis of transgenic mice blocks TGF-β-mediated growth inhibition. Proc Natl Acad Sci USA 1997; 94: 2386–91
   PubMed Web of Science ®Google Scholar
• Roberts AB. Transforming growth factor-β: activity and efficacy in animal models of wound healing. Wound Repair Regen 1995; 3: 408–18
   PubMedGoogle Scholar
• Cox DA. Transforming growth factor beta 3. Cell Biol Int 1995; 19: 357–71
   PubMed Web of Science ®Google Scholar
• Mustoe TA, Landes A, Cromack DT, Mistry D, Griffin A, Deuel TF, et al. Differential acceleration of healing of surgical incisions in the rabbit gastrointestinal tract by platelet derived growth factor and transforming growth factor beta 1. Surgery 1990; 198: 324–30
   Google Scholar
• Ernst H, Konturek P, Hahn EG, Brzozowski T, Konturek SJ. Acceleration of wound healing in gastric ulcers by local injection of neutralising antibody to transform growth factor β1. Gut 1996; 39: 172–5
   PubMed Web of Science ®Google Scholar
• Inauen W, Whyss PA, Baumgartner CC, Schiirer-Maly HR, Koelz HR. Influence of prostaglandins, omeprazole and indo-methacin on healing of experimental gastric ulcers in the rat. Gastroenterology 1988; 95: 636–41
   PubMed Web of Science ®Google Scholar
• Bravo R, Frank R, Blundell R, Mc Donald-Bravo H. Cyclin\ PCNA is the auxiliary protein of DNA polymerase. Nature 1987; 326: 515–7
   PubMed Web of Science ®Google Scholar
• Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981; 29: 577–80
   PubMed Web of Science ®Google Scholar
• Dignas U, Podolsky DK. Cytokine modulation of intestinal epithelial cell restitution: central role of transforming growth factor β. Gastroenterology 1993; 105: 1323–32
   PubMed Web of Science ®Google Scholar
• Zioncheck TF, Chen SA, Richardson L, et al. Pharmakocinetics and tissue distribution of recombinant human transforming growth factor betal after topical and intravenous administration in male rats. Pharm Res 1994; 11: 213–20
   PubMed Web of Science ®Google Scholar
• Chari R, Price D, Jirtle R. Down-regulation of transforming growth factor β receptor type I, II and III during liver regeneration. Am J Surg 1995; 169: 126–32
   PubMed Web of Science ®Google Scholar
• Konturek PH, Brzozowski T, Konturek SJ, Ernst H, Drozdowicz D, Pajdo R. Expression of epidermal growth factor and transforming growth factor alpha during ulcer healing. Time sequence study. Scand J Gastroenterol 1997; 32: 6–15
   PubMed Web of Science ®Google Scholar
• Beck LS, DeGuzman Lee WP, Xu Y, Siegel MW, Amento WP. One systemic administration of transforming growth factor beta 1 reverses age-or glucocorticoid-impaired wound healing. J Clin Invest 1993; 92: 2841–9
   PubMed Web of Science ®Google Scholar